His life is written in the lines of his face. What’s the

His life is written
in the lines of his face.
What’s the
next chapter?
Exercise and health
education in the Man Plan®
PBS Information: Authority Required (STREAMLINED: 3229). Locally advanced (equivalent to stage C)
or metastatic (equivalent to stage D) carcinoma of the prostate.
Please review Product Information before prescribing. To have a copy of the Product
Information sent to you telephone: 1800 043 460.
MINIMUM PRODUCT INFORMATION Lucrin Depot Prefilled Dual-Chamber Syringe (PDS) Injection (Sterile leuprorelin acetate for suspension) INDICATIONS Palliative treatment of metastatic or
locally extensive prostatic cancer (Stage C and D). CONTRAINDICATIONS Nonapeptide and excipient hypersensitivity; pregnancy; lactation PRECAUTIONS Urinary tract obstructions; hyperglycaemia,
increased risk of developing diabetes, increased risk of developing myocardial infarction, sudden cardiac death and stroke have been reported in men receiving GnRH agonists; QT prolongation;
metastatic vertebral lesions, bone mineral density changes, convulsions. ADVERSE EFFECTS ‘Flare’ phenomenon; hot flushes; sweats; peripheral oedema; GI upset; testosterone effects; pain; dyspnoea;
asthenia. Reported for Depot 3 Month and Depot 4 Month only: nervous system disturbances; arthralgia; myalgia; respiratory disorders; urinary disorders; skin reactions; others. See full PI. DOSAGE
Intramuscular injection. Vary site of administration. 7.5mg injection monthly. 22.5mg injection 3 monthly. 30mg injection 4 monthly. DATE OF PREPARATION January
2013, based on Product Information last updated January 2013, Version 08. Reference: 1. The Man Plan Patient Support Program, developed by AbbVie Pty Ltd, Oct
2010. ®Registered trademark of AbbVie Pty Ltd. ABN 48 156 384 262. 32-34 Lord Street, Botany NSW 2019. Ph: 1800 043 460. AU-LUC-2013-55a June 2013